189 related articles for article (PubMed ID: 37277751)
21. Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer.
Sugai T; Yamada N; Osakabe M; Hashimoto M; Uesugi N; Eizuka M; Tanaka Y; Sugimoto R; Yanagawa N; Matsumoto T
Histopathology; 2021 Oct; 79(4):584-598. PubMed ID: 33884652
[TBL] [Abstract][Full Text] [Related]
22. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.
Liu J; Huang C; Peng C; Xu F; Li Y; Yutaka Y; Xiong B; Yang X
BMC Cancer; 2018 Nov; 18(1):1099. PubMed ID: 30419872
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
24. Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance.
Uchihara T; Miyake K; Yonemura A; Komohara Y; Itoyama R; Koiwa M; Yasuda T; Arima K; Harada K; Eto K; Hayashi H; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Yashiro M; Masuda M; Ajani JA; Tan P; Baba H; Ishimoto T
Cancer Res; 2020 Aug; 80(16):3222-3235. PubMed ID: 32605995
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the expression of cancer-associated fibroblast- and EMT-related proteins in submucosal invasive colorectal cancer.
Sugai T; Uesugi N; Kitada Y; Yamada N; Osakabe M; Eizuka M; Sugimoto R; Fujita Y; Kawasaki K; Yamamoto E; Yamano H; Suzuki H; Matsumoto T
J Cancer; 2018; 9(15):2702-2712. PubMed ID: 30087711
[No Abstract] [Full Text] [Related]
26. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
[TBL] [Abstract][Full Text] [Related]
27. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
28. Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts.
Dong R; Guo J; Zhang Z; Zhou Y; Hua Y
Biochem Biophys Res Commun; 2018 Mar; 497(4):1129-1134. PubMed ID: 29499193
[TBL] [Abstract][Full Text] [Related]
29. Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.
Ock CY; Nam AR; Bang JH; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
Gastric Cancer; 2017 Jan; 20(1):164-174. PubMed ID: 26681196
[TBL] [Abstract][Full Text] [Related]
30. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
[TBL] [Abstract][Full Text] [Related]
31. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer.
Yang KD; Wang Y; Zhang F; Li QL; Luo BH; Feng DY; Zeng ZJ
Mol Cell Biochem; 2022 Nov; 477(11):2493-2505. PubMed ID: 35588343
[TBL] [Abstract][Full Text] [Related]
32. [Multiplex fluorescent imaging of cancer-associated fibroblasts in colorectal cancer].
Oleynikova NA; Kharlova OA; Danilova NV; Malkov PG
Arkh Patol; 2022; 84(5):11-19. PubMed ID: 36178217
[TBL] [Abstract][Full Text] [Related]
33. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
34. CD10
Cancer Discov; 2018 Mar; 8(3):264. PubMed ID: 29420180
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma.
Chen L; Chen M; Han Z; Jiang F; Xu C; Qin Y; Ding N; Liu Y; Zhang T; An Z; Guo C
J Clin Pathol; 2018 Aug; 71(8):721-728. PubMed ID: 29559517
[TBL] [Abstract][Full Text] [Related]
36. Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.
Zhu X; Han S; Wu S; Bai Y; Zhang N; Wei L
Exp Cell Res; 2019 Feb; 375(2):41-50. PubMed ID: 30611739
[TBL] [Abstract][Full Text] [Related]
37. High expression of fibroblast-activating protein is a prognostic marker in non-small cell lung carcinoma.
Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
Thorac Cancer; 2022 Aug; 13(16):2377-2384. PubMed ID: 35818720
[TBL] [Abstract][Full Text] [Related]
38. Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers.
Fukagawa D; Sugai T; Osakabe M; Suga Y; Nagasawa T; Itamochi H; Sugiyama T
Oncotarget; 2018 Jun; 9(44):27514-27524. PubMed ID: 29938002
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer.
Ucaryilmaz Metin C; Ozcan G
BMC Cancer; 2022 Jun; 22(1):692. PubMed ID: 35739492
[TBL] [Abstract][Full Text] [Related]
40. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer.
Ham IH; Oh HJ; Jin H; Bae CA; Jeon SM; Choi KS; Son SY; Han SU; Brekken RA; Lee D; Hur H
Mol Cancer; 2019 Mar; 18(1):68. PubMed ID: 30927911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
